Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium acetate, quantity: 3.68 g/l; potassium chloride, quantity: 370 mg/l; magnesium chloride hexahydrate, quantity: 300 mg/l; sodium gluconate, quantity: 5.02 g/l; sodium chloride, quantity: 5.26 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections - plasma-lyte 148 (approx. ph 7.4) iv infusion is indicated as a source of water and electrolytes or as an alkalinising agent.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium gluconate, quantity: 5.02 g/l; sodium acetate, quantity: 3.68 g/l; sodium chloride, quantity: 5.26 g/l; magnesium chloride hexahydrate, quantity: 300 mg/l; potassium chloride, quantity: 370 mg/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections - plasma-lyte 148 (approx. ph 7.4) iv infusion is indicated as a source of water and electrolytes or as an alkalinising agent.

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate ; sodium gluconate - solution for infusion - 148 (ph 7.4) - solutions affecting the electrolyte balance; electrolytes

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (sodium cation - unii:lyr4m0nh37, gluconic acid - unii:r4r8j0q44b), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - uni - sodium chloride 0.53 g in 100 ml - this solution is indicated for use in adults as a source of electrolytes and water for hydration, and as an alkalinizing agent. contraindications: none known. accurate clinical and laboratory estimation of fluid and electrolyte balance in order to access benefit/risk ratio are essential prior to administration of this solution (see warnings and precautions ).

United States - English - NLM (National Library of Medicine)

staples - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic to decrease bacteria on the skin

United States - English - NLM (National Library of Medicine)

staples - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic - to decrease bactgeria on the skin

United States - English - NLM (National Library of Medicine)

worklifebrands llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic to decrease bacteria on the skin

United States - English - NLM (National Library of Medicine)

worklifebrands llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic - to decrease bactgeria on the skin

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b, sodium cation - unii:lyr4m0nh37), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) ( magnesium cation - unii:t6v3lhy838, chloride ion - un - multiple electrolytes injection, type 1, usp, ph 7.4 is indicated as a source of water and electrolytes or as an alkalinizing agent. multiple electrolytes injection, type 1, usp, ph 7.4 is contraindicated in patients with a known hypersensitivity to the product. see warnings . for information on risk of air embolism – see dosage and administration. check solution container composition, lot number, and expiry date. parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. do not use solution containers in series connections. do not remove solution container from its overwrap until immediately before use. the intact port caps provide visual tamper evidence. do not use if a port cap is prematurely removed. maintain strict aseptic technique during handling. to open - always inspect the solution container before and after removal from the overwrap. - place the solution container on a clean, flat surface. using the

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b, sodium cation - unii:lyr4m0nh37), sodium acetate (unii: 4550k0sc9b) (acetate ion - unii:569dqm74sc, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - uni - multiple electrolytes injection, type 1, usp, ph 5.5 is indicated as a source of water and electrolytes or as an alkalinizing agent. multiple electrolytes injection, type 1, usp, ph 5.5 is contraindicated in patients with a known hypersensitivity to the product. see warnings . for information on risk of air embolism – see dosage and administration. check solution container composition, lot number, and expiry date. parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. do not use solution containers in series connections. do not remove solution container from its overwrap until immediately before use. the intact port caps provide visual tamper evidence. do not use if a port cap is prematurely removed. maintain strict aseptic technique during handling. to open - always inspect the solution container before and after removal from the overwrap. - place the solution container on a clean, flat surface. using the